Why Dopaminergic RLS Treatments Can Make Symptoms Worse Over Time

Restless Legs Syndrome (RLS), also known as Willis–Ekbom Disease, is a neurological condition that causes an uncomfortable urge to move the legs, particularly in the evening and at night.¹ Many people living with RLS describe it as crawling, tingling, buzzing, or “deep discomfort” in their legs, sensations that make it nearly impossible to sit still or fall asleep.

Because these symptoms can be so disruptive, many people work closely with their healthcare providers to find a restless legs syndrome treatment that brings relief. Dopaminergic drugs – such as ropinirole, pramipexole, and rotigotine – modulate the brain’s dopamine system and initially provide substantial relief of RLS symptoms for most patients. Unfortunately, it is now well understood that long-term use of these drugs cause changes to the dopamine system that make RLS symptoms much worse in the long run. For example, RLS symptoms may seem more intense, start earlier in the day, or spread to other parts of the body.

If you’ve noticed this happening, you’re not alone, and there’s a name for this drug-induced RLS worsening: augmentation.

For patients with augmentation who are experiencing moderate-severe RLS symptoms, additional increases in dopaminergic drug dosage can provide temporarily relief but ultimately makes RLS even worse – this is analogous to fighting fire with gasoline. Fortunately, there are multiple prescription alternatives to increasing dopaminergic dosage that we will discuss here.

A Common and Often Misunderstood Condition

RLS affects millions of people worldwide. Research from 2024 shows that about 7% of adults experience symptoms that meet diagnostic criteria for the condition. ³ In the United States, an AASM survey found that 13% of adults report an RLS diagnosis. ⁴ That means restless legs are more common than many realize.

For many people, RLS symptoms are more than just uncomfortable; they can interfere with sleep, work, travel, daily routines, and mental well-being. ⁵ When sleep becomes disrupted night after night, it’s natural to seek out a treatment plan that offers relief. But not every treatment is effective for long-term use, and that’s where augmentation may come in.

What Is Augmentation?

Augmentation is a treatment-related worsening of RLS symptoms that occurs after long-term use of dopaminergic medications. ⁶ These treatments are often very effective at first, but over time, they change the brain and make RLS worse.

Common signs of augmentation include:

• Symptoms starting earlier in the afternoon or evening
• Feeling restless more quickly after sitting or lying down
• Stronger or more uncomfortable sensations
• Symptoms spreading beyond the legs
• Medication providing shorter-lasting relief

Many people misinterpret augmentation as their RLS “getting worse” and thus seek increases in dosage. But augmentation is different; it’s related to how your body adapts to certain medications over time. ⁷ Increasing dosage will just make this problem worse in the long run.

Understanding this difference can help you have more productive conversations with your healthcare provider.

Why Augmentation Matters

Augmentation can leave many people feeling confused, stressed, or frustrated. You might start taking your medication earlier, taking additional doses, or still not getting the same relief you once did. ⁸

Because augmentation can mimic regular RLS progression, it’s often overlooked. Recognizing the pattern helps you understand what’s happening in your body and puts you in a better position to explore new options with your provider.

How Common Is Augmentation?

Augmentation is not rare, especially for people using dopaminergic treatments long-term:

• About 8% of people each year experience augmentation during the first several years of treatment. ⁹
• After three years, 20–30% may experience noticeable symptom changes. ¹⁰
• A 2025 study showed 15% stopped medication because of augmentation alone.¹¹
• 50-70% of patients experience significant augmentation within 10 years

If your restless legs have changed over time, even if you’ve been taking your medication exactly as prescribed, augmentation may be part of the reason.

Risk Factors: Why Some People Experience Augmentation

Not everyone taking medication will experience significant augmentation. But certain factors may make it more likely: ⁶

• Taking dopamine-based medication for many years
• Using daily doses above the FDA indicated maximums of pramipexole or ropinirole
• Having low iron levels (even without anemia)
• Experiencing severe RLS symptoms from the start
• Having certain genetic markers (such as MEIS1 or BTBD9)¹²

These don’t guarantee augmentation, but they simply explain why it may affect some people and not others.

How to Recognize Augmentation in Everyday Life

Since augmentation can look a lot like regular RLS symptoms, it helps to pay attention to changes such as:

• “My restless legs start in the afternoon now, not just at night.”
• “My medication doesn’t last as long as it used to.”
• “The sensations feel stronger or different.”
• “It’s spreading to my arms or hands.”

Other things — such as low iron, certain medications, or sleep disorders — can also make RLS worse.¹³ That’s why noticing changes early and discussing them with your provider is so important.

Talking to Your Healthcare Provider

Instead of giving medical instructions, this section focuses on what patients can ask, which complies with the client’s request.

If your symptoms have changed, try discussing:

• How have your symptoms shifted over time
• Whether your current restless legs syndrome treatment might be contributing
• Whether alternative, non-dopaminergic treatments may be available
• Whether checking iron levels makes sense for you
• Whether drug-free options may be appropriate
• What lifestyle adjustments may support symptom relief

You don’t have to figure it out alone. Your provider is your partner in navigating these changes.

Long-Term Care and Feeling Empowered

Living with RLS is a journey, and every person’s experience is unique. Keeping a simple symptom journal (noting timing, intensity, and patterns) can help you recognize changes earlier and have clearer conversations with your provider.

It’s also important to remember this:

If your treatment stops working the same way or begins making symptoms worse, you haven’t done anything wrong. Augmentation is a known and manageable effect of dopaminergic medications.

Many people explore complementary or drug-free remedies for restless legs, including wearable technologies. Solutions like Nidra® therapy, which uses high-frequency peroneal nerve stimulation, are designed to help calm leg sensations and support better sleep without medication. For those who want a non-pharmacologic option, this approach can be an appealing part of long-term management.

New Research and What’s Ahead

Genetic Advances

Research is uncovering genes involved in RLS and dopamine regulation (especially MEIS1 and BTBD9), which may help predict who is more likely to experience augmentation.¹²

This could open doors to more personalized care.

Long-Term Treatment Insights

The National RLS Opioid Registry followed people for five years and found many maintained stable symptom control with closely supervised, low-dose therapy.¹⁵ This reinforces that treatment must be individualized rather than one-size-fits-all.

Updated Clinical Guidelines for Treating RLS

The 2025 clinical practice guidelines from the American Academy of Sleep Medicine highlight a growing emphasis on avoiding dopaminergic drugs and addressing brain iron deficiency.⁶ These guidelines also recommend in favor of Nidra, gabapentinoid drugs, and certain opioids.

Conclusion

Augmentation can feel overwhelming, but it’s both common and manageable. It doesn’t mean your RLS is naturally getting worse — it means your dopaminergic medication that used to provide benefit is now exacerbating your RLS.

By noticing changes early, staying informed, and working with your provider to explore all available options — including drug-free treatment for restless leg syndrome such as Nidra — many people find long-term relief and better sleep.

Restless Legs Syndrome is a lifelong condition for some, but with knowledge, support, and the right tools, you can move toward steadier, more comfortable nights.

1. Allen RP et al., 2014
Allen RP, Picchietti DL, Garcia-Borreguero D, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. Sleep Med. 2014;15(8):860–873.

2. Allen RP et al., 2014 – Updated RLS Diagnostic Criteria
Allen RP, Picchietti DL, Garcia-Borreguero D, et al.
Sleep Med. 2014;15(8):860–873.

3. Young T et al., 2024
Young T, Finn L, Peppard PE, et al. Epidemiology of restless legs syndrome: a systematic review. Sleep Med Rev. 2024;68:101724.

4. AASM RLS Public Survey, 2023
American Academy of Sleep Medicine. Restless Legs Syndrome Awareness & Diagnosis – Public Survey.

5. Garcia-Borreguero & Williams, 2014
Garcia-Borreguero D, Williams AM. An update on the pathophysiology and treatment of RLS. Curr Treat Options Neurol. 2014;16:282.

6. AASM Clinical Practice Guidelines for RLS, 2025
American Academy of Sleep Medicine. 2025 Clinical Practice Guideline for the Treatment of Restless Legs Syndrome and PLMD.

7. Trenkwalder, Allen & Högl, 2023
Trenkwalder C, Allen RP, Högl B. Mechanisms and prevention of augmentation in restless legs syndrome. Sleep Med. 2023;104:115–122.

8. Buchfuhrer MJ et al., 2021
Buchfuhrer MJ, et al. Long-term dopamine agonist therapy and augmentation in RLS. J Clin Sleep Med. 2021;17(8):1685–1694.

9. Earley & Silber, 2010
Earley CJ, Silber MH. Restless legs syndrome: augmentation and risk factors. Sleep Med. 2010;11(4):504–512.

10. Garcia-Borreguero et al., 2016
Garcia-Borreguero D, Kohnen R, Högl B, et al. Long-term treatment of RLS/WED: evidence-based guidelines and consensus recommendations. Sleep Med. 2016;17:86–98.

11. Kim J et al., 2025
Kim J, Cho YW, Allen RP, et al. Medication discontinuation due to augmentation in restless legs syndrome: a multicenter observational study. Sleep. 2025;48(2):zsad005.

12. Schormair B et al., 2017 (MEIS1 & BTBD9 genetics)
Schormair B, Zhao C, Bell S, et al. Novel risk loci for restless legs syndrome identified by GWAS. Nat Genet. 2017;49(7):1198–1203.

13. Aurora RN et al., 2021
Aurora RN, Kristo DA, Bista SR, et al. The treatment of restless legs syndrome and periodic limb movement disorder in adults—update for 2021. Sleep. 2021;44(8):zsab131.

15. National RLS Opioid Registry Study, 2023
Trenkwalder C, Winkelman JW, Paulus W, et al. Five-year outcomes from the National RLS Opioid Registry. Sleep. 2023;46(10):zsad150.

 

MKT-01078 v01

 

Introduction

If you live with Restless Legs Syndrome (RLS), you understand it’s more than just a nightly annoyance. The uncontrollable urge to move your legs, paired with strange sensations, especially at rest or at night, can steal not only sleep, but peace of mind. Over time, disrupted nights lead to groggy mornings, mood shifts, foggy thinking, and frustration.

RLS is more common than many realize. A 2024 global systematic review estimated that about 7.1% of adults worldwide live with RLS, with women affected more often than men (8.3% vs 6.0%)¹. In the U.S., a 2024 American Academy of Sleep Medicine survey reported that 13% of adults have been diagnosed with RLS². These numbers highlight how widespread the condition is and why safe, effective treatment options are in high demand.

Medications have their place, but many people want relief without the side effects or want to combine drug and non-drug strategies. The good news: clinical trial results from 2019 through 2025 are increasingly supporting non-drug options, giving hope for safer, sustainable symptom control.

Why Consider Drug-Free Approaches?

Traditional treatments like dopamine agonists, gabapentinoids, and opioids can reduce RLS symptoms. However, they all carry risks:

• Augmentation (symptoms worsen or begin earlier in the day).
• Side effects like fatigue, weight gain, dizziness, and nausea.
• Potential for dependency (especially in long-term or high-dose use).

Because of such concerns, many providers and patients are turning their attention to drug-free options, which carry fewer risks and may also address underlying mechanisms of RLS, including iron deficiency and abnormal nerve signaling that devices like Nidra® are designed to modulate.

Nutritional & Supplement Options

IV Iron Therapy

Brain iron deficiency is strongly linked to RLS and is independent of anemia. Dr. Andrew Spector, Professor of Neurology and RLS specialist at Duke University, believes in the importance of iron therapy. He notes, “Iron is foundational to the successful treatment of RLS. I am very aggressive with making sure my patients with RLS have high levels of iron.” The research supports this approach.

• A 2025 meta-analysis of 7 trials (539 RLS patients) found that intravenous ferric carboxymaltose reduced symptom severity on the IRLS scale compared to placebo, along with improvements in sleep and quality of life scores³.
• A 2024 pilot trial comparing IV iron with oral iron in RLS patients with iron-deficiency anemia found both treatments significantly improved symptoms by week 6, suggesting that addressing iron deficiency, by any route can provide meaningful relief⁴.
• Importantly, even RLS patients with ferritin levels between 100–300 µg/L (often considered “normal”) showed significant improvement after a 1000 mg IV ferric carboxymaltose infusion in a 2025 study⁵.

Pros: Can provide substantial and lasting symptom relief, though improvement often develops gradually over several weeks to two months.

Cons: Requires infusion in a medical setting; potential cost and availability issues; mild side effects like flushing and muscle aches are more common than with a placebo, though severe events are rare; Often takes 2 months after infusion for improvement in RLS.

Oral Iron & Other Nutrients

Not everyone needs IV treatment. Oral iron supplementation can also help, though results are more modest and may take longer to achieve.

• In a 2024 randomized study, about 40–47% of RLS patients on oral iron achieved significant symptom improvement⁴.
• A meta-analysis showed moderate improvements in sleep quality, IRLS scores, and quality-of-life measures after 2–14 weeks of iron supplementation³.

Supplementation of other vitamins and minerals, such as Vitamin D, may reduce RLS symptoms in some situations, but rigorous clinical trials are needed.

Device-Based Therapy: Nidra®

Nidra is drug-free and clinically proven to reduce RLS symptoms.

Among the most exciting advances in RLS care is Nidra®, a first-of-its-kind, drug-free wearable therapy that delivers Tonic Motor Activation® (TOMAC®), a patented form of high-frequency peroneal nerve stimulation. Unlike medication, Nidra targets the neurological pathways at the root of RLS, helping to normalize overactive nerve activity that drives restless sensations.

How it works:

Nidra uses two small, lightweight therapy units worn just below the knees. When activated, they gently engage specific nerves on the side of each leg. This new technology is personalized to your unique needs to deliver rapid, lasting relief from RLS symptoms starting in less than 30 minutes⁶ ⁷.

Clinically validated results:

• Nidra is the first and only drug-free therapy clinically proven to reduce RLS symptoms and improve sleep quality.
• In clinical research, 91% of patients reported an improvement in RLS symptoms after eight weeks of therapy⁸ ⁹.
• Patients experienced more nights free from RLS symptoms and no risk of medication-related side effects⁸ ⁹.
• The 2025 AASM Clinical Practice Guidelines include peroneal nerve stimulation therapy with a favorable recommendation for RLS management¹⁰.

What patients are saying:

“Therapy has been fantastic and life-changing.”
“Success! I love the feel when they are activated. I’m very excited about these results.”
“Nidra is a lifesaver! I don’t know what I would do without it!”

Pros: Non-invasive, personalized, and sleep-compatible therapy that provides meaningful relief without drugs or side effects; proven to improve RLS symptoms and sleep quality.

Access: Prescription required. Coverage is expanding across major insurance providers, and Noctrix Health offers dedicated onboarding and support to help patients stay consistent and experience relief.

Lifestyle & Behavioral Strategies

Lifestyle choices don’t cure RLS, but they can help reduce symptom severity:

• Sleep hygiene: A consistent bedtime, a cool/dark sleep environment, and avoiding caffeine or alcohol in the evening can reduce RLS symptoms.
• Exercise: Regular moderate activity is linked with lower RLS burden, but strenuous workouts shortly before bedtime can worsen symptoms.
• Leg care routines: Stretching, warm baths, massage, or gentle yoga before bed can provide short-term relief.

Epidemiological studies in 2024 confirm that RLS severity is higher in patients with obesity, poor general health, diabetes, or kidney disease, reinforcing the role of lifestyle management alongside medical care⁶.

When to See a Specialist

Specialist input can be invaluable if:

• Symptoms are frequent or severe enough to disrupt sleep.
• Blood work indicates iron therapy is appropriate.
• Lifestyle and behavioral strategies haven’t provided enough relief.

Your health care provider or a specialist can tailor a plan that may include iron supplementation, Nidra, medication, or combined approaches.

Real-World Stories

• In a 2025 trial, nearly 70% of RLS patients receiving IV iron reported significant improvement by week 6³.
• In a 2023 trial, 91% of RLS patients receiving Nidra therapy reported RLS symptom improvement by week 8 7.
• In oral iron studies, roughly 4 in 10 patients improved enough to be considered responders⁴.

Conclusion

With millions of adults worldwide living with RLS and up to 13% of Americans already diagnosed — drug-free strategies aren’t just alternative options, they’re essential tools for managing symptoms and improving life quality.

If you have RLS:

1. Ask your provider about iron testing (serum ferritin and transferrin saturation).
2. Explore lifestyle strategies like better sleep habits and regular movement.
3. Discuss whether oral iron, IV iron, or device-based therapies could be right for you.
4. Talk to your provider about Nidra® therapy — a clinically proven, FDA-cleared, drug-free option designed to reduce RLS symptoms and improve sleep quality.¹⁰
5. Track your symptoms; noting when and how they occur helps you and your provider refine your plan over time.
6. Confirm that your provider is familiar with the 2025 AASM Clinical Practice Guidelines for the treatment of RLS.¹⁰

Drug-free treatments won’t look the same for every patient, but the growing evidence shows they can be an important alternative or supplement to medication. To find the best treatment for your restless legs syndrome symptoms, ask your health care provider about seeing an RLS specialist.

References

1. Global prevalence of restless legs syndrome: A systematic review and meta-analysis (2024)
2. AASM Survey: 13% of U.S. adults diagnosed with RLS (2024)
3. Khan A, et al. Intravenous ferric carboxymaltose for restless legs syndrome: Meta-analysis of 7 trials (2025)
4. Short V, et al. Randomized double-blind pilot study: Oral vs IV iron in RLS patients with iron deficiency anemia (2024)
5. Ferric carboxymaltose improves RLS symptoms even with normal ferritin (100–300 µg/L) (2025)
6. Matar E, et al. Risk factors and lifestyle links with RLS severity (2024)
7. Noctrix Health. Data on File. CL-9 Report. Duration of relief from a single 30-minute session of NTX100 TOMAC.
8. Buchfuhrer MJ, et al. J Clin Sleep Med. 2021;17(8):1685–1694.
9. Bogan RK, et al. Efficacy and safety of tonic motor activation (TOMAC) for medication-refractory restless legs syndrome: A randomized clinical trial. Sleep. 2023;46(10).

MKT-01061 v01